JTH/LinkedIn
Jun 23, 2026, 13:44
How Sickle Hemoglobin Fuels Thrombosis and Vascular Injury – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Jintao Wang et al, published in Journal of Thrombosis and Haemostasis, adding:
“Sickle hemoglobin promotes venous thrombosis through procoagulant activity and is targetable by hemoglobinase therapy
In sickle cell disease mice, sickle hemoglobin shortens clotting time and drives venous thrombosis, while hemoglobinase (plasmepsin I) therapy reduces free hemoglobin and thrombus size.”
Title: Sickle hemoglobin promotes venous thrombosis through procoagulant activity and is targetable by hemoglobinase therapy
Authors: Jintao Wang, Paul Silaghi, Daniel T. Eitzman
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 23, 2026, 12:45Lina Camacho-Arteaga: ENTIS Study Uncovers Safety Data on Early Pregnancy Exposure to Direct Oral Anticoagulants
-
Sep 23, 2026, 12:34Hiteshi K.C. Chauhan: Why Mechanical Valve Thrombosis Is a Systems Failure, Not Just an Anticoagulation Error
-
Sep 23, 2026, 12:33World Thrombosis Day 2026 Puts Women’s Health in Focus – JTH
-
Sep 23, 2026, 12:30Zain Khalpey: How a Sudden Blockage Causes Myocardial Infarction
-
Sep 23, 2026, 12:16Apurva Popat: When Heparin Triggers Thrombosis
-
Sep 23, 2026, 12:14Zahra Ghasemi: The Power of Voluntary Blood Donation
-
Sep 23, 2026, 12:04Leo Nicolai: Activated Platelets Get Trapped in the Spleen During Thrombosis
-
Sep 23, 2026, 12:01Francisco Chacón-Lozsán: Rethinking PE Risk in 2026
-
Sep 23, 2026, 11:58Ifeanyichukwu Ifechidere: Factor V Leiden Requires Context Beyond the Genetic Result